Condition: Peripheral Nerve Injury Upper Limb · Peripheral Nerve Injury (PNI) · Sponsor: Neuraptive Therapeutics Inc.
NTX-001 is a single use surgical product intended for use in conjunction with standard suture neurorrhaphy of severed nerves in patients between 18 and 80.
This description comes directly from the study's public registry record.
Seth Schulman, MD · 215-206-9504 · seth.schulman@neuraptive.com
Kristen Olszyk, MS · 484-753-1205 · kristen.olszyk@neuraptive.com
Always discuss trial participation with your own doctor first.
| Cedars Sinai Medical Center | Los Angeles, California, United States | Not Yet Recruiting |
| Rothman Orthopedics - Advent Health | Orlando, Florida, United States | Recruiting |
| Orlando Health Orlando Regional Medical Center | Orlando, Florida, United States | Recruiting |
| Grady Health | Atlanta, Georgia, United States | Recruiting |
| University of Chicago | Chicago, Illinois, United States | Recruiting |
| University of Louisville | Louisville, Kentucky, United States | Not Yet Recruiting |
| Louisiana State University Health Sciences Center | New Orleans, Louisiana, United States | Recruiting |
| Curtis National Center at MedStar Union Memorial Hospital | Baltimore, Maryland, United States | Recruiting |
| Missouri Orthopaedic Institute | Columbia, Missouri, United States | Recruiting |
| Barnes-Jewish Hospital 1 Barnes Jewish Hospital Plaza St. | St Louis, Missouri, United States | Recruiting |
| The Cooper Health System | Camden, New Jersey, United States | Recruiting |
| NYU Langone Health | New York, New York, United States | Recruiting |
+ 12 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06616025